Anal Cancer | Tumor

CURE’s anal cancer page is an extensive resource of cancer information featuring the latest anal cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on anal cancer.

FDA Approves Age Expansion of HPV Vaccine

October 6th 2018, 1:05am

Article

The Food and Drug Administration (FDA) approved an expanded age indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), according to Merck, the manufacturer of the HPV vaccine.

Driving Research in Rare Cancers

August 7th 2018, 8:13pm

Article

Research continues to drive the oncology field.

Down to the Almighty Dollar: Socioeconomic Status Can Affect Cancer Outcomes

July 25th 2018, 4:58pm

Article

A recent study found that socioeconomic status can play a role in survival for patients with anal cancer.

NCCN Establishes Guidelines for Treating People With HIV and Cancer

February 27th 2018, 7:38pm

Article

Treatment of HIV has drastically improved since the 1980s, but many of these individuals are still facing barriers to proper cancer care.

Immunotherapy Treatment Advances in Anal Cancer

August 3rd 2017, 5:34pm

Article

More personalized approaches are being developed to treat patients with metastatic disease.

Despite Benefits, HPV Vaccination Rates Remain Too Low

May 18th 2017, 6:16pm

Article

Despite impressive efficacy for the human papillomavirus (HPV) vaccine reducing the prevalence of high-risk oral HPV infections by 88 percent, many young adults still are not getting the vaccine – sparking concern in the health community.

Opdivo Is Promising for Advanced Anal Cancer, Study Shows

April 11th 2017, 8:51pm

Article

The PD-1 inhibitor, Opdivo, may be a promising option for patients with advanced anal cancer, according to a recent study.

As HPV-Related Cancer Rates Rise, Vaccination Numbers Remain Low

January 27th 2017, 10:02pm

Article

From stigma to convenience, there are many reasons why people do not get the HPV vaccine, although it can prevent some types of cancer. Lois Ramondetta, M.D., discusses updated recommendations and hopes for getting more young people vaccinated.

Encouraging Phase 2 Trial Data Seen With Immunotherapy in Metastatic Anal Cancer

July 12th 2016, 11:54pm

Article

Opdivo may be a promising treatment option for patients with squamous cell carcinoma of the anal canal.

HPV Vaccination in Boys Found Cost-Effective in Preventing Oropharyngeal Cancer

April 17th 2015, 9:24pm

Article

A new study has shown that vaccinating adolescent boys may be cost-effective for preventing oropharyngeal cancer, a disease that's projected to become the most common HPV-related cancer by 2020.